<DOC>
	<DOCNO>NCT01776047</DOCNO>
	<brief_summary>Study Design : randomize , open label , single-dose , 2-way cross-over design Phase : Phase I</brief_summary>
	<brief_title>A Randomized , Open Label , Single Dose , 2-Way Cross-over Clinical Trial Compare Safety Pharmacokinetic Characteristics Exforge® G-0081 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Amlodipine , Valsartan Drug Combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>healthy male volunteer age 20 50 year old within range ±20 % IBW ( Ideal Body Weight ) neither congenital/chronic disease pathological symptoms/findings result medical examination doctor determine suitable subject within 4 week ago administration Hypersensitivity ( history hypersensitivity ) amlodipine valsartan Active Liver Diseases exceed 1.5 time normal range AST , ALT Gastrointestinal diseases surgery affect absorption drug Excessive drinking ( exceed 30g/week ) excessive caffeine ( exceed 250mg/day ) Smoking 10 cigarette per day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>